Literature DB >> 16036347

Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase.

Maria Pia Rigobello1, Alessandra Folda, Maria Cristina Baldoin, Guido Scutari, Alberto Bindoli.   

Abstract

The mitochondrial production of hydrogen peroxide, in the presence of different respiratory substrates (succinate, glutamate, malate and isocitrate), is stimulated by submicromolar concentrations of auranofin, a highly specific inhibitor of thioredoxin reductase. This effect is particularly evident in the presence of antimycin. Auranofin was also able to unmask the production of hydrogen peroxide occurring in the presence of rotenone. However, at variance with whole mitochondria, auranofin does not stimulate hydrogen peroxide production in submitochondrial particles indicating that it does not alter the formation of hydrogen peroxide by the respiratory chain but prevents its removal. As the mitochondrial metabolism of hydrogen peroxide proceeds through the peroxidases linked to glutathione or thioredoxin, the relative efficiency of the two systems and the effects of auranofin were tested. In conclusion, the inhibition of thioredoxin reductase determines an increase of the basal flow of hydrogen peroxide leading to a more oxidized condition that alters the mitochondrial functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16036347     DOI: 10.1080/10715760500135391

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  30 in total

1.  Thioredoxin reductase-2 is essential for keeping low levels of H(2)O(2) emission from isolated heart mitochondria.

Authors:  Brian A Stanley; Vidhya Sivakumaran; Sa Shi; Iain McDonald; David Lloyd; Walter H Watson; Miguel A Aon; Nazareno Paolocci
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

2.  Drug repurposing for gastrointestinal stromal tumor.

Authors:  Ziyan Y Pessetto; Scott J Weir; Geetika Sethi; Melinda A Broward; Andrew K Godwin
Journal:  Mol Cancer Ther       Date:  2013-05-08       Impact factor: 6.261

Review 3.  Gold-based therapy: From past to present.

Authors:  Alice Balfourier; Jelena Kolosnjaj-Tabi; Nathalie Luciani; Florent Carn; Florence Gazeau
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

4.  A Quantitative Chemoproteomic Platform to Monitor Selenocysteine Reactivity within a Complex Proteome.

Authors:  Daniel W Bak; Jinjun Gao; Chu Wang; Eranthie Weerapana
Journal:  Cell Chem Biol       Date:  2018-07-05       Impact factor: 8.116

5.  Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.

Authors:  William C Stafford; Xiaoxiao Peng; Maria Hägg Olofsson; Xiaonan Zhang; Diane K Luci; Li Lu; Qing Cheng; Lionel Trésaugues; Thomas S Dexheimer; Nathan P Coussens; Martin Augsten; Hanna-Stina Martinsson Ahlzén; Owe Orwar; Arne Östman; Sharon Stone-Elander; David J Maloney; Ajit Jadhav; Anton Simeonov; Stig Linder; Elias S J Arnér
Journal:  Sci Transl Med       Date:  2018-02-14       Impact factor: 17.956

6.  Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.

Authors:  Michelle Kiebala; Jolanta Skalska; Carla Casulo; Paul S Brookes; Derick R Peterson; Shannon P Hilchey; Yun Dai; Steven Grant; Sanjay B Maggirwar; Steven H Bernstein
Journal:  Exp Hematol       Date:  2014-10-22       Impact factor: 3.084

7.  Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia.

Authors:  S Talbot; R Nelson; W T Self
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

8.  Effects of Mammalian Thioredoxin Reductase Inhibitors.

Authors:  Elias S J Arnér
Journal:  Handb Exp Pharmacol       Date:  2021

Review 9.  TrxR1 as a potent regulator of the Nrf2-Keap1 response system.

Authors:  Marcus Cebula; Edward E Schmidt; Elias S J Arnér
Journal:  Antioxid Redox Signal       Date:  2015-06-24       Impact factor: 8.401

10.  Inhibition of glutathione and thioredoxin metabolism enhances sensitivity to perifosine in head and neck cancer cells.

Authors:  Andrean L Simons; Arlene D Parsons; Katherine A Foster; Kevin P Orcutt; Melissa A Fath; Douglas R Spitz
Journal:  J Oncol       Date:  2009-09-02       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.